BillionToOne: Tom Lynch

Dec 02, 2022

Molecular diagnostics developer BillionToOne has appointed Tom Lynch as general counsel and chief compliance officer. Lynch most recently served as chief compliance officer, advanced healthcare solutions at Fortive. He has also been the chief legal officer at Nuwellis and chief administrative officer and general counsel at Orexigen Therapeutics. Earlier in his career, Lynch held senior legal and compliance positions at Boston Scientific and Novartis Pharma. He holds a bachelor's degree from Stanford University and a JD from Boston College Law School.

BillionToOne: Tom Lynch

Cerebral Palsy Sequencing Study Finds Clinically Actionable Alterations

Lucid Diagnostics Raises $22M in Convertible Debt Refinancing

Medicover Genetics Receives IVDR Certification for Genetic Testing Reagent Kit

Final FDA Guidance Lays Path for Drugmakers to Establish Circulating Tumor DNA as Trial Endpoint

Multi-Ancestry Study Uncovers Genetic Contributors to Progressive Eye Disease